Nestle's Maggi 'shock therapy'

The crisis galvanised the multinational to accelerate the pace of new product launches to regain leadership in its core markets

Arnab Dutta  |  New Delhi 

Sometime in the late afternoon of May 17, Nestle India's stock was trading at Rs 9,865 a piece at the Bombay Stock Exchange (BSE). The price was nearly the double the low point it touched since a crisis that seriously threatened the company in 2015.

That was when a panicky government, spooked by allegations of contaminants in Maggi instant noodles, imposed a country-wide ban on Nestle's crown jewel. Last fortnight's stock market performance — the highest price since Nestle listed on the Indian bourses in 1996 — saw the company briefly enter the league of ...

First Published: Tue, May 29 2018. 20:28 IST